Rochelle Hines

Associate Professor, Department of Psychology
Expertise: Neurodevelopmental disorders, Autism spectrum disorders, Schizophrenia, Epilepsy, Pharmacology, Molecular genetics, Biochemistry

Biography

Rochelle Hines is an assistant professor of neuroscience in 51³Ô¹ÏºÚÁÏ's psychology department. Her research focuses on improving understanding of neurodevelopmental disorders and promoting novel therapeutic strategies.

For example, Hines' research has examined normal and abnormal brain function in conditions such as autism spectrum disorders, schizophrenia, and developmental epilepsies. She is particularly interested in understanding how various processes during brain development impact signaling and circuitry between cells, as well as behavior. She is a co-director of the Hines Group Comprehensive Neuroscience Lab, which recently delved into the possible medical benefits of psychedelics and other psychoactive compounds.

In addition to research and teaching, Hines mentors and oversees research by high school, undergraduate, graduate, and postdoctoral students. In 2021, her lab received funding from the National Institutes of Health for an initiative to improve collaborative biomedical research efforts in the American West, as well as from the National Institutes of Neurological Disorders and Stroke to further research in that field.

 

Education

  • CIHR Postdoctoral Fellowship, Tufts University School of Medicine
  • Ph.D., Neuroscience, University of British Columbia

Rochelle Hines In The News

Marijuana Moment
In December 2020, Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter. The COVID pandemic was still in full swing, and that year’s fire season had been extreme.
Nevada Current
In December 2020, Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter. The COVID pandemic was still in full swing, and that year’s fire season had been extreme.
MDLinx
The US Drug Enforcement Administration (DEA) plans to reclassify marijuana to a Schedule III controlled substance from Schedule I. This shift would not only recognize the drug’s medicinal uses, but also acknowledge that it has less potential for abuse.
Las Vegas Review Journal
While most psychedelic drugs remain illegal, that could change as their health benefits become more widely known both in the United States and Nevada, where further psychedelic-assisted therapy could be on the horizon.

Articles Featuring Rochelle Hines

Rochelle Hines smiling and sitting on couch
People | February 4, 2025

Psychology professor's research helps provide a more thorough understanding of autism spectrum disorders, schizophrenia, and developmental epilepsies.

Remember sculptor Claes Oldenburg who created U.N.L.V.'s iconic Flashlight sculpture this month.
Campus News | August 3, 2022

A collection of news stories highlighting university experts’ insights on and contributions to health, environment, and society.

U.N.L.V. Football players entering Allegiant Stadium
Campus News | May 2, 2022

A collection of news stories highlighting the experts and student changemakers at 51³Ô¹ÏºÚÁÏ.